Canadian medical marijuana company Aurora Cannabis Inc. ACB ACB announced its collaboration Wednesday with a research grant provided to the University of British Columbia (UBC) by Genome British Columbia.
What Happened: The project, Genomics-Enabled Aroma Breeding in Cannabis, is being led by Drs. Jose Celedon, principal scientist of breeding and genetics at Aurora and Joerg Bohlmann, a professor at UBC. The project focuses on validating genetic and chemical markers for fruity aroma in cannabis.
Why It Matters: This genetics research is in line with Aurora’s breeding goals by enabling it to enhance its breeding program with greater accuracy and efficiency on consumer-focused traits, positively impacting future innovation.
“Through this work, Aurora will deepen our understanding of cannabis genetics with a focus on aromas, a leading driver of consumer preference that directly impacts the user experience,” Celedon said. “By collaborating with UBC on this Genome BC-funded project, we are able to fully execute this aroma research without the typical financial constraints, allowing us to continue simultaneous work on additional important breeding traits, such as yield, potency and disease resistance."
Read Also: What gives weed its unique aroma? (Hint: it’s not just terpenes)
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
Why Is Aroma Important?
Aroma is a distinct characteristic of cannabis and an important aspect of consumer inclination.
According to earlier research, the pleasant aroma can be a determining factor in a more positive individual experience, rather than THC potency, dose or terpene expression.
The group of scientists, led by Dr. Ethan Russo as part of the 2022 study, focused on identifying which marijuana features affect its overall appeal.
Based on the data analyzed by independent researchers, a “pleasant subjective aroma” seems to be a "predictive of pleasant subjective effects," the paper noted. Surprisingly, terpene expression as well as THC potency and dose proved to be a less important indicator of the quality of consumed cannabis.
Now, via this new partnership with Genome British Columbia, Aurora intends to move beyond sensory analysis and into validated aroma markers.
Aurora previously patented a series of genetic and chemical markers for fruity aroma, which were identified through its CanD diversity panel. The new collaboration will allow it to validate these markers using cutting-edge approaches that would otherwise require significant funding.
What's Next: The data generated from this work will support the discovery and launch of cultivars with unique and improved aromas, alongside high yield and potency, Aurora said in a press release.
Read Next:
ACB Price Action
Aurora’s shares traded 0.19% higher at $5.41 per share during the pre-market session on Wednesday morning.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.